TYRA

$34.04-0.71 (-2.04%)

Pre-Market$34.04+0.00 (+0.00%)· Last close May 1

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO